Reumatología Clínica

Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease? Fatih Albayrak; Mustafa Gür; Ahmet Karataş; Süleyman Serdar Koca; Bünyamin Kısacık;

Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice Jordi Gratacós-Masmitja; Emma Beltrán Catalán; José Luis Álvarez Vega; Ana Urruticoechea-Arana; Concepción Fito; Francisco Maceiras; Joaquín María Belzunegui Otano; Julia Fernández Melón; Eugenio Chamizo Carmona; Miguel Ángel Abad Hernández; Inmaculada Ros Vilamajó; Sonia Castro Oreiro; Eva Pascual Alfonso; Juan Carlos Torre Alonso;

La actividad de la artritis psoriásica con afectación axial se correlaciona con el PsAID12 Jose Antonio Pinto Tasende; Carlota Laura Iñiguez Ubiaga; Victor Eliseo Quevedo Vila; Luis Fernández Dominguez; Francisco Jose Maceiras Pan; Carlos García Porrúa;